CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: fenoldopam
Accession: CHEBI:5002
browse the term
Definition: A benzazepine that has formula C16H16ClNO3.
Synonyms: exact_synonym: 6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
related_synonym: Formula=C16H16ClNO3; InChI=1S/C16H16ClNO3/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21/h1-4,7,13,18-21H,5-6,8H2; InChIKey=TVURRHSHRRELCG-UHFFFAOYSA-N; SMILES=Oc1ccc(cc1)C1CNCCc2c(Cl)c(O)c(O)cc12; fenoldopamum
xref: CAS:67227-56-9; DrugBank:DB00800; Drug_Central:1153; KEGG:C07693; KEGG:D07946; LINCS:LSM-1609
xref_mesh: MESH:D018818
xref: Patent:DE2751258; Patent:US4197297; Wikipedia:Fenoldopam
G
A3galt2
alpha 1,3-galactosyltransferase 2
increases expression
EXP
Fenoldopam results in increased expression of A3GALT2 mRNA
CTD
PMID:21983523
NCBI chr 5:141,101,329...141,113,760
Ensembl chr 5:141,107,983...141,115,641
G
Abl2
ABL proto-oncogene 2, non-receptor tyrosine kinase
increases expression
EXP
Fenoldopam results in increased expression of ABL2 mRNA
CTD
PMID:21983523
NCBI chr13:68,673,702...68,770,846
Ensembl chr13:68,673,722...68,839,742
G
Actg1
actin, gamma 1
increases expression
EXP
Fenoldopam results in increased expression of ACTG1 mRNA
CTD
PMID:21983523
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Adam9
ADAM metallopeptidase domain 9
increases expression
EXP
Fenoldopam results in increased expression of ADAM9 mRNA
CTD
PMID:21983523
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
decreases expression
EXP
Fenoldopam results in decreased expression of ADAMTS4 mRNA
CTD
PMID:21983523
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
G
Atp2b2
ATPase plasma membrane Ca2+ transporting 2
decreases expression
EXP
Fenoldopam results in decreased expression of ATP2B2 mRNA
CTD
PMID:21983523
NCBI chr 4:146,894,602...147,208,060
Ensembl chr 4:146,896,332...147,140,665
G
B4galt1
beta-1,4-galactosyltransferase 1
increases expression
EXP
Fenoldopam results in increased expression of B4GALT1 mRNA
CTD
PMID:21983523
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
G
Calu
calumenin
increases expression
EXP
Fenoldopam results in increased expression of CALU mRNA
CTD
PMID:21983523
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
G
Cbx7
chromobox 7
decreases expression
EXP
Fenoldopam results in decreased expression of CBX7 mRNA
CTD
PMID:21983523
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
G
Cd55
CD55 molecule (Cromer blood group)
increases expression
EXP
Fenoldopam results in increased expression of CD55 mRNA
CTD
PMID:21983523
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
G
Ckap4
cytoskeleton-associated protein 4
increases expression
EXP
Fenoldopam results in increased expression of CKAP4 mRNA
CTD
PMID:21983523
NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914
G
Clic1
chloride intracellular channel 1
increases expression
EXP
Fenoldopam results in increased expression of CLIC1 mRNA
CTD
PMID:21983523
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
G
Col12a1
collagen type XII alpha 1 chain
increases expression
EXP
Fenoldopam results in increased expression of COL12A1 mRNA
CTD
PMID:21983523
NCBI chr 8:80,547,592...80,665,665
Ensembl chr 8:80,547,593...80,665,686
G
Drd1
dopamine receptor D1
affects response to substance multiple interactions
EXP
DRD1 protein affects the susceptibility to Fenoldopam Fenoldopam binds to and results in increased activity of DRD1 protein
CTD
PMID:1724532 PMID:8103596
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Ecm2
extracellular matrix protein 2
decreases expression
EXP
Fenoldopam results in decreased expression of ECM2 mRNA
CTD
PMID:21983523
NCBI chr17:15,120,194...15,152,536
Ensembl chr17:15,120,196...15,152,516
G
Eng
endoglin
increases expression
EXP
Fenoldopam results in increased expression of ENG mRNA
CTD
PMID:21983523
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
G
Enpp3
ectonucleotide pyrophosphatase/phosphodiesterase 3
increases expression
EXP
Fenoldopam results in increased expression of ENPP3 mRNA
CTD
PMID:21983523
NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041
G
Erp29
endoplasmic reticulum protein 29
increases expression
EXP
Fenoldopam results in increased expression of ERP29 mRNA
CTD
PMID:21983523
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
G
Fgf2
fibroblast growth factor 2
increases expression
EXP
Fenoldopam results in increased expression of FGF2 protein
CTD
PMID:12180796
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fn1
fibronectin 1
increases expression
EXP
Fenoldopam results in increased expression of FN1 mRNA
CTD
PMID:21983523
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
EXP
Fenoldopam results in decreased expression of HMGCS2 mRNA
CTD
PMID:21983523
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Kdelr3
KDEL endoplasmic reticulum protein retention receptor 3
increases expression
EXP
Fenoldopam results in increased expression of KDELR3 mRNA
CTD
PMID:21983523
NCBI chr 7:111,079,236...111,089,463
Ensembl chr 7:111,079,218...111,101,600
G
Kpna2
karyopherin subunit alpha 2
increases expression
EXP
Fenoldopam results in increased expression of KPNA2 mRNA
CTD
PMID:21983523
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
G
Lgmn
legumain
increases expression
EXP
Fenoldopam results in increased expression of LGMN mRNA
CTD
PMID:21983523
NCBI chr 6:121,544,048...121,582,495
Ensembl chr 6:121,544,053...121,582,480
G
Litaf
lipopolysaccharide-induced TNF factor
increases expression
EXP
Fenoldopam results in increased expression of LITAF mRNA
CTD
PMID:21983523
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
G
Loxl2
lysyl oxidase-like 2
increases expression
EXP
Fenoldopam results in increased expression of LOXL2 mRNA
CTD
PMID:21983523
NCBI chr15:44,683,449...44,773,067
Ensembl chr15:44,683,880...44,773,067
G
Lrat
lecithin retinol acyltransferase
increases expression
EXP
Fenoldopam results in increased expression of LRAT mRNA
CTD
PMID:21983523
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
G
Myct1
myc target 1
increases expression
EXP
Fenoldopam results in increased expression of MYCT1 mRNA
CTD
PMID:21983523
NCBI chr 1:42,018,137...42,029,410
Ensembl chr 1:42,018,137...42,029,410
G
Nfkbiz
NFKB inhibitor zeta
increases expression
EXP
Fenoldopam results in increased expression of NFKBIZ mRNA
CTD
PMID:21983523
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Nos2
nitric oxide synthase 2
increases expression
EXP
Fenoldopam results in increased expression of NOS2 protein
CTD
PMID:12180796
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nrip3
nuclear receptor interacting protein 3
increases expression
EXP
Fenoldopam results in increased expression of NRIP3 mRNA
CTD
PMID:21983523
NCBI chr 1:163,789,738...163,815,036
Ensembl chr 1:163,789,738...163,815,600
G
Omd
osteomodulin
decreases expression
EXP
Fenoldopam results in decreased expression of OMD mRNA
CTD
PMID:21983523
NCBI chr17:15,060,217...15,068,441
Ensembl chr17:15,060,217...15,068,441
G
Pdia6
protein disulfide isomerase family A, member 6
increases expression
EXP
Fenoldopam results in increased expression of PDIA6 mRNA
CTD
PMID:21983523
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
G
Pgk1
phosphoglycerate kinase 1
increases expression
EXP
Fenoldopam results in increased expression of PGK1 mRNA
CTD
PMID:21983523
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
G
Plp2
proteolipid protein 2
increases expression
EXP
Fenoldopam results in increased expression of PLP2 mRNA
CTD
PMID:21983523
NCBI chr X:14,834,249...14,837,648
Ensembl chr X:14,834,231...14,838,514
G
Pros1
protein S
increases expression
EXP
Fenoldopam results in increased expression of PROS1 mRNA
CTD
PMID:21983523
NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
G
Ptrh1
peptidyl-tRNA hydrolase 1 homolog
increases expression
EXP
Fenoldopam results in increased expression of PTRH1 mRNA
CTD
PMID:21983523
NCBI chr 3:16,064,867...16,071,098
Ensembl chr 3:16,064,880...16,070,648
G
Ran
RAN, member RAS oncogene family
increases expression
EXP
Fenoldopam results in increased expression of RAN mRNA
CTD
PMID:21983523
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
G
Rangap1
RAN GTPase activating protein 1
increases expression
EXP
Fenoldopam results in increased expression of RANGAP1 mRNA
CTD
PMID:21983523
NCBI chr 7:113,224,695...113,250,441
Ensembl chr 7:113,224,703...113,250,438
G
S100a11
S100 calcium binding protein A11
increases expression
EXP
Fenoldopam results in increased expression of S100A11 mRNA
CTD
PMID:21983523
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
G
S100a4
S100 calcium-binding protein A4
increases expression
EXP
Fenoldopam results in increased expression of S100A4 mRNA
CTD
PMID:21983523
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
Slc2a4
solute carrier family 2 member 4
decreases expression
EXP
Fenoldopam results in decreased expression of SLC2A4 mRNA
CTD
PMID:21983523
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
G
Slc39a11
solute carrier family 39, member 11
increases expression
EXP
Fenoldopam results in increased expression of SLC39A11 mRNA
CTD
PMID:21983523
NCBI chr10:98,275,958...98,697,042
Ensembl chr10:98,275,960...98,611,295
G
Slc41a2
solute carrier family 41 member 2
increases expression
EXP
Fenoldopam results in increased expression of SLC41A2 mRNA
CTD
PMID:21983523
NCBI chr 7:20,383,714...20,491,178
Ensembl chr 7:20,383,757...20,491,166
G
Taar1
trace-amine-associated receptor 1
increases activity multiple interactions
ISO
Fenoldopam results in increased activity of TAAR1 protein [Fenoldopam results in increased activity of TAAR1 protein] which results in increased abundance of Cyclic AMP
CTD
PMID:19725810
NCBI chr 1:21,517,742...21,518,740
Ensembl chr 1:21,517,258...21,532,084
G
Tgfb1
transforming growth factor, beta 1
increases expression
EXP
Fenoldopam results in increased expression of TGFB1 protein
CTD
PMID:12180796
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Thbs1
thrombospondin 1
increases expression
EXP
Fenoldopam results in increased expression of THBS1 mRNA
CTD
PMID:21983523
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
EXP
Fenoldopam results in increased expression of TIMP1 mRNA
CTD
PMID:21983523
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tlr2
toll-like receptor 2
increases expression
EXP
Fenoldopam results in increased expression of TLR2 mRNA
CTD
PMID:21983523
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tmem97
transmembrane protein 97
increases expression
EXP
Fenoldopam results in increased expression of TMEM97 mRNA
CTD
PMID:21983523
NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730
G
Tnc
tenascin C
increases expression
EXP
Fenoldopam results in increased expression of TNC mRNA
CTD
PMID:21983523
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnfsf10
TNF superfamily member 10
decreases expression
EXP
Fenoldopam results in decreased expression of TNFSF10 mRNA
CTD
PMID:21983523
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tpm4
tropomyosin 4
increases expression
EXP
Fenoldopam results in increased expression of TPM4 mRNA
CTD
PMID:21983523
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
G
Tubb4b
tubulin, beta 4B class IVb
increases expression
EXP
Fenoldopam results in increased expression of TUBB4B mRNA
CTD
PMID:21983523
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
increases expression
EXP
Fenoldopam results in increased expression of TUBB5 mRNA
CTD
PMID:21983523
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tubb6
tubulin, beta 6 class V
increases expression
EXP
Fenoldopam results in increased expression of TUBB6 mRNA
CTD
PMID:21983523
NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418
G
Ube2l3
ubiquitin-conjugating enzyme E2L 3
increases expression
EXP
Fenoldopam results in increased expression of UBE2L3 mRNA
CTD
PMID:21983523
NCBI chr11:83,797,722...83,838,862
Ensembl chr11:83,797,722...83,838,862
G
Vcan
versican
increases expression
EXP
Fenoldopam results in increased expression of VCAN mRNA
CTD
PMID:21983523
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
G
Vwf
von Willebrand factor
affects expression
EXP
Fenoldopam affects the expression of VWF protein
CTD
PMID:11026604
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all